Celltrion News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Celltrion. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Celltrion Today - Breaking & Trending Today
Celltrion, a major Korean pharmaceutical company, has developed a new autoimmune disease treatment device known as Zymfentra. It is the company s first self-developed medical product that will debut in the United States, and is on its way to becoming a major success story in the North American country s medical industry, according to the company, Monday. ....
Korean biopharmaceutical firm Celltrion said Thursday its fourth-quarter net income plunged 99.4 percent from a year earlier due to sluggish sales. ....
Late last month, a Patent Trial and Appeal Board ("PTAB") panel instituted two petitions that were filed separately by Celltrion and Biocon for inter partes review ("IPR") of Regeneron's U.S. ....
On Friday, January 20, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") filed an ex parte application for a scheduling order setting the schedule for preliminary injunction proceedings or, in the alternative, an emergency status conference. ....